Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1935 1
1937 1
1947 1
1948 1
1951 1
1958 1
1970 2
1971 2
1975 1
1976 2
1977 4
1980 3
1982 2
1983 2
1984 3
1986 4
1987 1
1988 1
1989 6
1990 1
1991 2
1992 2
1993 7
1994 7
1995 3
1996 4
1997 3
1998 3
1999 10
2000 5
2001 8
2002 13
2003 14
2004 14
2005 17
2006 22
2007 15
2008 17
2009 14
2010 25
2011 25
2012 22
2013 42
2014 37
2015 36
2016 29
2017 36
2018 39
2019 40
2020 48
2021 50
2022 47
2023 54
2024 56
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

745 results

Results by year

Filters applied: . Clear all
Page 1
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Among authors: gunther a. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
Fatigue in Adults: Evaluation and Management.
Latimer KM, Gunther A, Kopec M. Latimer KM, et al. Among authors: gunther a. Am Fam Physician. 2023 Jul;108(1):58-69. Am Fam Physician. 2023. PMID: 37440739 Free article.
Evidence for a lipofibroblast-to-Cthrc1 + myofibroblast reversible switch during the development and resolution of lung fibrosis in young mice.
Lingampally A, Truchi M, Mauduit O, Delcroix V, Vasquez-Pacheco E, Gautier-Isola M, Chu X, Khadim A, Chao CM, Zabihi M, Taghizadeh S, Rivetti S, Marega M, Moiseenko A, Hadzic S, Vazquez-Armendariz AI, Herold S, Günther S, Millar-Büchner P, Koepke J, Samakovlis C, Wilhelm J, Bartkuhn M, Braun T, Weissmann N, Zhang J, Wygrecka M, Makarenkova HP, Günther A, Seeger W, Chen C, El Agha E, Mari B, Bellusci S. Lingampally A, et al. Among authors: gunther a. Eur Respir J. 2025 Feb 6;65(2):2300482. doi: 10.1183/13993003.00482-2023. Print 2025 Feb. Eur Respir J. 2025. PMID: 39401861 Free PMC article.
Lung Cancer and Interstitial Lung Diseases.
Drakopanagiotakis F, Krauss E, Michailidou I, Drosos V, Anevlavis S, Günther A, Steiropoulos P. Drakopanagiotakis F, et al. Among authors: gunther a. Cancers (Basel). 2024 Aug 13;16(16):2837. doi: 10.3390/cancers16162837. Cancers (Basel). 2024. PMID: 39199608 Free PMC article. Review.
Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis.
Kheirollahi V, Wasnick RM, Biasin V, Vazquez-Armendariz AI, Chu X, Moiseenko A, Weiss A, Wilhelm J, Zhang JS, Kwapiszewska G, Herold S, Schermuly RT, Mari B, Li X, Seeger W, Günther A, Bellusci S, El Agha E. Kheirollahi V, et al. Among authors: gunther a. Nat Commun. 2019 Jul 5;10(1):2987. doi: 10.1038/s41467-019-10839-0. Nat Commun. 2019. PMID: 31278260 Free PMC article.
CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD.
Wu CY, Cilic A, Pak O, Dartsch RC, Wilhelm J, Wujak M, Lo K, Brosien M, Zhang R, Alkoudmani I, Witte B, Pedersen F, Watz H, Voswinckel R, Günther A, Ghofrani HA, Brandes RP, Schermuly RT, Grimminger F, Seeger W, Sommer N, Weissmann N, Hadzic S. Wu CY, et al. Among authors: gunther a. Am J Respir Crit Care Med. 2023 Jun 15;207(12):1576-1590. doi: 10.1164/rccm.202208-1603OC. Am J Respir Crit Care Med. 2023. PMID: 37219322
Highlighting fibroblast plasticity in lung fibrosis: the WI-38 cell line as a model for investigating the myofibroblast and lipofibroblast switch.
Vásquez-Pacheco E, Marega M, Lingampally A, Fassy J, Truchi M, Goth K, Trygub L, Taghizadeh S, Bartkuhn M, Alexopoulos I, Dong Y, Lebrigand K, Gunther A, Chen C, Zhang J, Chao CM, Al Alam D, El Agha E, Mari B, Bellusci S, Rivetti S. Vásquez-Pacheco E, et al. Among authors: gunther a. Theranostics. 2024 Jun 11;14(9):3603-3622. doi: 10.7150/thno.93519. eCollection 2024. Theranostics. 2024. PMID: 38948058 Free PMC article.
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
Veith C, Vartürk-Özcan I, Wujak M, Hadzic S, Wu CY, Knoepp F, Kraut S, Petrovic A, Gredic M, Pak O, Brosien M, Heimbrodt M, Wilhelm J, Weisel FC, Malkmus K, Schäfer K, Gall H, Tello K, Kosanovic D, Sydykov A, Sarybaev A, Günther A, Brandes RP, Seeger W, Grimminger F, Ghofrani HA, Schermuly RT, Kwapiszewska G, Sommer N, Weissmann N. Veith C, et al. Among authors: gunther a. Circulation. 2022 Mar 22;145(12):916-933. doi: 10.1161/CIRCULATIONAHA.121.057001. Epub 2022 Feb 17. Circulation. 2022. PMID: 35175782
Identification of Paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in pulmonary fibrosis.
Marchal-Duval E, Homps-Legrand M, Froidure A, Jaillet M, Ghanem M, Lou D, Justet A, Maurac A, Vadel A, Fortas E, Cazes A, Joannes A, Giersh L, Mal H, Mordant P, Piolot T, Truchin M, Mounier CM, Schirduan K, Korfei M, Gunther A, Mari B, Jaschinski F, Crestani B, Mailleux AA. Marchal-Duval E, et al. Among authors: gunther a. Elife. 2023 Jun 1;12:e79840. doi: 10.7554/eLife.79840. Elife. 2023. PMID: 37261432 Free PMC article.
745 results